NCR3 and neoplasm: For ACEhi-specific signals, in contrast, an inhibitory ligand-receptor pair BAG6-NCR3, who serves as suppressing NK cell activation [60], was found to act as major signaling from DC and tumor cells to NK cells (Supplementary Fig. S6e; Fig. 5f and g).